ArticlePloS one2021

Correction: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.

Septelia Inawati Wanandi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.